Sep 11, 2017
Histone deacetylase ( HDAC ) inhibitors are a new class of anti-cancer agents which play important roles in epigenetic or non-epigenetic regulation, including programmed cell death, and cell cycle arrest in cancer cells. Histone deacetylase inhibitors are either naturally occurring or they can be synthetically produ...
Read More...
Sep 24, 2024
Amyotrophic Lateral Sclerosis (ALS) is a devastating neurodegenerative disease characterized by the progressive degeneration of motor neurons, leading to muscle weakness, paralysis, and ultimately, death. Over the past decade, a growing understanding of the disease's underlying mechanisms has led to significant adv...
Read More...
Sep 07, 2017
Two ongoing CAR-T Phase I trials of Cellectis drug candidate has been put on hold by FDA after a patient’s death FDA has put two CAR-T trials on hold following a patient’s death, less than a week after the first ever CAR-T was approved by the US regulatory agency. The patient (78) was suffering from r...
Read More...
Sep 05, 2017
Cancer by Numbers provide us with the degree of devastation it has incurred among various populations, and provides us with a better idea on the level of progress needed to eradicate this morbid indication. It also sheds light on the blockbuster drugs along with potential therapies for the cancer. Click Here For Do...
Read More...
Aug 31, 2017
Japanese researchers report promising results from an experimental therapy for Parkinson’s disease that involves implanting neurons made from ‘reprogrammed’ stem cells into the brain. A trial conducted in monkeys with a version of the disease showed that the treatment improved their symptoms and seemed to be safe, a...
Read More...
Aug 28, 2017
Bruton's Tyrosine Kinase (BTK) is a cytoplasmic member from the Tec (tyrosine kinase expressed in hepatocellular carcinoma) group of kinases which is engaged with controlling the B cell expansion and is essential in B-lymphocyte advancement, separation, and signaling. Bruton's tyrosine kinase; also known as tyrosine...
Read More...
Aug 25, 2017
Can-Fite Receives Milestone Payment from Korean Distribution Partner CKD Pharmaceuticals Can-Fite BioPharma Ltd., A Leading Biotechnology Company in the pharmaceutical industry advancing a pipeline of proprietary drugs that address various major indications related to liver, inflammatory diseases, and cancer, has an...
Read More...
Aug 23, 2017
CRISPR has been in the limelight for a very long time, and now it has again touched headlines, not for another milestone, but for a reason that might question the positive effects, it boasts of creating in the research sphere. Two independent researchers at Rockefeller University and New York University edited orco ...
Read More...
Aug 21, 2017
Ovarian Cancer is one of the commonly diagnosed cancer among women worldwide. It accounts for nearly 239,000 new cases and 152,000 deaths per year, globally. Treatment landscape of Ovarian Cancer has evolved over the years as the available chemotherapies were not that efficient, giving rise to targeted therapies as ...
Read More...
Aug 18, 2017
Friedreich's ataxia is one of the rare inherited nervous system disorder which causes movement abnormalities like slowed voluntary movement leading to gait disturbance and decreased coordination. It usually begins in childhood and leads to impaired muscle coordination (ataxia) that worsens gradually with time. In 18...
Read More...